Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage

Digestive and Liver Disease

Volumn 43, Issue 5, 2011, Pages 374-379

  Tursi, Antonio ^a   Elisei, Walter ^b   Brandimarte, Giovanni ^c   Giorgetti, Gian Marco ^d   Inchingolo, Cosimo Damiano ^e   Nenna, Rosanna ^e   Ierardi, Enzo ^f  

^a ASL BAT   (Italy)

^b ASL Roma H   (Italy)

^c Ospedale Cristo Re   (Italy)

^d S EUGENIO HOSPITAL   (Italy)

^e Ospedale Lorenzo Bonomo   (Italy)

^f UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Endoscopy; Segmental colitis associated with diverticulosis; Tumoural necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON DIVERTICULOSIS; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INJURY SEVERITY; IRRITABLE COLON; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; DIVERTICULOSIS, COLONIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79953283879     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.11.014     Document Type: Article

References (34)

1. Tursi A., Papagrigoriadis S. Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther 2009, 30:532-546.
2. Tursi A. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 2007, 8:299-307.
3. Tursi A., Elisei W., Brandimarte G., et al. The endoscopic spectrum of segmental colitis associated wuth diverticulosis. Colorectal Dis 2010, 12:464-470.
4. Harpaz N., Sachar D.B. Segmental colitis associated with diverticular disease and other IBD look-alikes. J Clin Gastroenterol 2006, 40:S132-S135.
5. Lamps L.W., Knapple W.L. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 2007, 5:27-31.
6. Murch S.H., Lamkin V.A., Savage M.O., et al. Serum concentrations of tumour necrosis factor a in childhood chronic inflammatory bowel disease. Gut 1991, 32:913-917.
7. Braegger C.P., Nicholls S., Murch S.H., et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992, 339:89-91.
8. Reinecker H-C., Steffen M., Witthoeft T., et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1b by isolated lamina propriamononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993, 94:174-181.
9. Plevy S.E., Landers C.J., Prehn J., et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997, 159:6276-6282.
10. Berner B., Akca D., Jung T., et al. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000, 27:1128-1135.
11. Murch S.H., Braegger C.P., Walker-Smith J.A., et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993, 34:1705-1709.
12. Hassan C., Ierardi E., Burattini O., et al. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. Dig Liver Dis 2007, 39:811-817.
13. Knight D.M., Trinh H., Le J., et al. Construction and initial characterization of a mouse-human chimeric anti-TNF-antibody. Mol Immunol 1993, 30:1443-1453.
14. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
15. Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549.
16. Sands B.E., Anderson F.H., Bernstein C.N., et al. Infliximab maintenance therapy for fistulising Crohn's disease. N Engl J Med 2004, 350:876-885.
17. Baert F.J., D'Haens G.R., Peeters M., et al. Tumour necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999, 116:22-28.
18. Ierardi E., Meucci G., Hassan C., et al. Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci 2008, 53:1865-1868.
19. Tursi A., Inchingolo C.D., Nenna R., et al. Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity. Inflamm Bowel Dis 2008, 14:1315-1317.
20. Hassan C., Zullo A., Ierardi E., et al. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut 2006, 55:589-590.
21. Rizzello F., Gionchetti P., D'Arienzo A., et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2002, 16:1109-1116.
22. Winship D.H., Summers R.W., Singleton J.W., et al. National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology 1979, 77:829-842.
23. Morson B.C., Dawson I.M.P. Gastro-intestinal pathology 1979, Blackwell Scientific Publications, Oxford, p. 530-3. 2nd edn.
24. Ierardi E., Monno R.A., Gentile A., et al. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol 2003, 54:774-777.
25. Makapugay L.M., Dean P.J. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996, 20:94-102.
26. Peppercorn M.A. Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 1992, 87:609-612.
27. Pereira M.C. Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc 1998, 48:520-523.
28. Gore S., Sheperd N.A., Wilkinson S.P. Endoscopic crescent fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis 1992, 7:76-81.
29. Koutroubakis I.E., Antoniou P., Tzardi M., et al. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis 2005, 20:28-32.
30. Olsen T., Goll R., Cui G., et al. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 2007, 42:1312-1320.
31. Ruffolo C., Scarpa M., Faggian D., et al. Cytokine network in rectal mucosa in perianal Crohn's disease: relations with inflammatory parameters and need for surgery. Inflamm Bowel Dis 2008, 14:1406-1412.
32. Imperiali G., Terpin M.M., Meucci G., et al. Segmental colitis associated with diverticula: a 7-year follow-up study. Endoscopy 2006, 38:610-612.
33. Freeman H. Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome). Dig Dis Sci 2008, 53:2452-2457.
34. Henriksen M., Jahnsen J., Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008, 57:1518-1523.